BMRA Wutah pendapatan kuartal marang kuartal Biomerica

Simbol lan logo merek Biomerica (BMRA)

The development of gastroenterology systems guarantees the fundamental stability of Biomerica, Inc. (BMRA). Reviewing the change in quarterly sales volume on GURU.Markets, it is evident that the current metric is -8.50. However, certification delays for new tests are hindering expansion, while high R&D costs coupled with a liquidity shortage are creating certain financial pressures, serving as critical benchmarks for the investor.

BMRA (Biomerica, Inc) riwayat Tingkat wutah pendapatan sajrone kuartal saka 04.07.2022 nganti 20.11.2026

Rincian metrik lan analitis perusahaan Biomerica (BMRA)

- kuotasi saiki lan rata-rata prakiraan nilai:
- data dhuwit lan arus kas:
Analisis wiwitan perusahaan:Biomerica Inc (BMRA)
Produk sing diprodhuksi biomerica.com

This indicator determines the rate of change in quarterly sales volume, allowing investors to detect business stagnation before financial reports are published. By analyzing the quarterly revenue chart on GURU.Markets, one can assess the resilience of Biomerica, Inc. (BMRA), whose strategy of diversifying diagnostic tests for laboratories and pharmacies ensures stable demand and the fundamental strength of the company's financial metrics.

Pesaing Biomerica, Inc. (BMRA)

A - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Quest Diagnostics Incorporated DGX|ILMN (illumina.com) - Wutah dodolan triwulanan|Wutah dodolan triwulanan Cologuard|RVTY (Revvity Corp) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Bio-Rad Laboratories Inc|Wutah dodolan triwulanan NNNN (Anbio Biotechnology)|SHC (Sotera Health Company) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal QuidelOrtho Inc. QDEL|Wutah pendapatan triwulanan OPKO Health Inc OPK|CareDx Inc - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan MRVI (Maravai)|FLGT: Wutah pendapatan triwulanan|LAB (Standard BioTools Inc.) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Cytek Biosciences Inc|Tingkat wutah pendapatan sajrone kuartal OraSure OSUR|Wutah dodolan triwulanan XGN (Exagen Diagnostics)|Tingkat wutah dodolan sajrone kuartal MDxHealth Inc.|Wutah pendapatan kuartal marang kuartal Lucid Diagnostics, Inc. LUCD|Prenetics Global Ltd (PRE) - Tingkat wutah pendapatan sajrone kuartal|Insight Molecular Diagnostics Inc - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal trinitybiotech.com|PRPH (ProPhase) - Wutah dodolan triwulanan|Wutah dodolan kuartal marang kuartal AIMD|Wutah dodolan triwulanan CODX|Tingkat wutah pendapatan sajrone kuartal heartsciences.com HSCS|Wutah pendapatan triwulanan CDIO|Onconetix - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal viraxbiolabs.com VRAX|Tingkat wutah dodolan sajrone kuartal Bluejay (BJDX)|AWH: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Accelerate Diagnostics, Inc. AXDX|Centogene (CNTG) - Wutah pendapatan kuartal marang kuartal|Dinamika pendapatan kuartal marang kuartal ENZ (Enzo)|Wutah dodolan kuartal marang kuartal Fresh2 (FRES)|Genetic Technologies (GENE) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan ME|Wutah pendapatan kuartal marang kuartal PMD (Psychemedics Corporation)